
    
      The primary objective of this study is to evaluate the efficacy and safety of buprenorphine
      transdermal system (BTDS) compared to placebo in subjects with moderate to severe
      osteoarthritic pain of the hip or knee who have a sub-optimal response to their non-opioid
      analgesic treatment and require opioid analgesics for pain control.
    
  